COVID-19, caused by the SARS-CoV-2 virus, is an infectious disease that primarily affects the respiratory tract and can manifest itself in a variety of forms, from asymptomatic to severe respiratory syndrome. The virus belongs to the coronavirus family and can be transmitted from person to person through respiratory droplets. In 2020, the World Health Organization (WHO) declared COVID-19 a pandemic, leading to global measures to control the spread of the infection. In addition to respiratory symptoms such as cough, shortness of breath, and fever, many patients report other manifestations of the disease, including fatigue, loss of smell, and taste. As the virus continues to mutate, the emergence of new strains has raised concerns about its potential pathogenicity and susceptibility to vaccines.
History of the disease and interesting historical facts
The first case of COVID-19 was reported in December 2019 in Wuhan, China. The virus was soon identified as a novel coronavirus and quickly spread around the world. Interestingly, coronaviruses have a long history, having been first discovered in the 1960s. There have been several previous outbreaks of coronavirus infections, such as SARS (in 2002-2003) and MERS (in 2012), which also caused public concern but did not reach pandemic proportions. In early 2020, unprecedented lockdown measures, including lockdowns and mandatory mask wearing, changed the way of life in many countries. Scientific research into the disease has led to the rapid development of effective vaccines, which has become one of humanity’s major victories in the fight against infection.
Epidemiology
Epidemiology COVID-19 is highly contagious, due to its ability to spread through small droplets emitted when coughing, sneezing or talking. As of early 2023, more than 650 million cases have been reported worldwide, and the number of deaths has exceeded 6 million. Statistics indicate that the fatality rate varies depending on age group, comorbidities and access to health care. Older patients and people with chronic diseases such as diabetes and cardiovascular disease are most susceptible to severe forms of the disease. Suboptimal vaccination among certain groups of the population has also affected the statistics of morbidity and mortality.
Genetic predisposition to this disease
Scientific research shows that there is a genetic predisposition to more severe forms of COVID-19. In particular, specific mutations in genes responsible for the immune response can increase susceptibility to infection and its severe course. Genetic variations, such as polymorphisms in the HLA (major histocompatibility complex) and ACE2 (the main receptor for SARS-CoV-2) genes, play a key role in determining the individual reactivity of the body to the virus. It has been found that patients with certain HLA alleles may have a significant advantage in eliminating the virus in the early stages of infection, while other variants may worsen the predisposition to severe clinical forms.
Risk factors for the development of this disease
Risk factors for the development of COVID-19 include both physical and chemical aspects. The main physical risk factors are:
- age (older people are more susceptible to severe forms)
- presence of chronic diseases (arterial hypertension, diabetes, obesity)
- weakened immune response (for example, in cancer or immunosuppressive therapy)
As for chemical factors, studies show that high levels of air pollution can influence the severity of the disease. This is because pollutants can weaken the immune defenses of the respiratory system, making it more vulnerable to viruses. Psychosocial factors, such as stress levels, can also influence susceptibility to the disease.
Diagnosis of this disease
Diagnosis of COVID-19 begins with an assessment of clinical symptoms. The main symptoms include:
- fever
- cough
- acute dyspnea
- fatigue
- loss of smell and taste
Laboratory tests are used to confirm the diagnosis, including PCR tests that detect the presence of viral RNA. Antigen tests are also used for rapid diagnosis. Radiological tests, such as chest X-rays and CT scans, can be used to evaluate the lungs. Differential diagnosis is important to exclude other respiratory diseases, such as influenza or pneumonia. Serological tests may also be used to detect the presence of antibodies, which helps in assessing previous infection and immune response.
Treatment
Treatment of COVID-19 depends on the severity of the disease. Main areas:
- general treatment (isolation of the patient, supportive therapy)
- pharmacological treatment (use of antiviral drugs such as remdesivir and corticosteroids to reduce the inflammatory response)
- surgical treatment (in rare cases, medical intervention may be required, such as intubation for respiratory failure)
- other treatments (antibody-rich plasma, use of monoclonal antibodies)
Pharmacological therapy has its own characteristics depending on the clinical course. For example, in mild cases, symptomatic treatment is used, and in severe forms - combinations of antiviral and anti-inflammatory drugs.
List of medications used to treat this disease
Among the main drugs approved for the treatment of COVID-19, the following can be distinguished:
- Remdesivir
- Dexamethasone
- Molnupiravir
- Paxlovid
- Monoclonal antibodies (eg, bamlanivimab and etesemivimab)
The preference for prescribing one drug or another depends on the severity of the disease and individual patient factors.
Disease monitoring
Monitoring a patient with COVID-19 involves regular monitoring of symptoms and laboratory parameters. Monitoring steps may include:
- daily monitoring of temperature and oxygen saturation levels
- conducting periodic tests for the presence of the virus
- monitoring of blood biochemical parameters
The prognosis of the disease depends on many factors, including the patient’s age, the presence of comorbidities, and the quality of treatment received. Complications can include pulmonary edema, thrombosis, and acute respiratory distress syndrome, which highlights the importance of prompt treatment.
Age-related features of the disease
COVID-19 manifests itself differently depending on the age group. Children tend to have mild or asymptomatic illness. Older patients, especially those with chronic diseases, are more susceptible to serious consequences. Research shows that after the age of 60, the risk of severe COVID-19 increases significantly, which leads to necessary precautions such as vaccination and social distancing.
Questions and Answers
- How quickly do COVID-19 symptoms appear? Symptoms can appear anywhere from 2 to 14 days after infection, with an average of about 5-6 days.
- Is it safe to get vaccinated after having COVID-19? Yes, vaccination after an illness helps strengthen the immune response.
- Can vaccinated people become infected with COVID-19? Yes, but the likelihood of a severe course of the disease is much lower.
- How long does immunity last after vaccination? Studies show that the protective effect may last for several months, but revaccination may be required.
- What to do when the first symptoms of the disease appear? It is important to isolate yourself and see a doctor for diagnosis and treatment.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends monitoring your condition and not ignoring the first symptoms of COVID-19. Important:
- Take precautions - wear a mask, avoid crowds and wash your hands regularly.
- Conduct vaccination and revaccination to increase the level of protection.
- Monitor changes in your health and seek medical attention if you feel unwell.
Following these recommendations will help reduce the risk of the disease and its complications.
